Dysregulation of transforming growth factor ? signaling in scleroderma: Overexpression of endoglin in cutaneous scleroderma fibroblasts-Reference-Cited by-同舟云学术

Dysregulation of transforming growth factor ? signaling in scleroderma: Overexpression of endoglin in cutaneous scleroderma fibroblasts

Published:2002-07 Issue:7 Volume:46 Page:1857-1865
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Leask A.,Abraham D. J.,Finlay D. R.,Holmes A.,Pennington D.,Shi-Wen X.,Chen Y.,Venstrom K.,Dou X.,Ponticos M.,Black C.,Jackman J. K.,Findell P. R.,Connolly M. K.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference34 articles.

1. The aetiopathogenesis of systemic sclerosis

2. A Possible Role for Transforming Growth Factor-β in Systemic Sclerosis

3. Role of Transforming Growth Factor β in Human Disease

4. TGFβ—a role in systemic sclerosis?

5. Transcription and Expression of Transforming Growth Factor Type Beta in the Skin of Progressive Systemic Sclerosis: A Mediator of Fibrosis?

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifaceted TGF‐β signaling, a master regulator: From bench‐to‐bedside, intricacies, and complexities;Cell Biology International;2023-10-19

2. Modulation of Neuroimmune and Epithelial Dysregulation in Patients With Moderate to Severe Prurigo Nodularis Treated With Nemolizumab;JAMA Dermatology;2023-09-01

3. Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease;International Journal of Molecular Sciences;2022-12-30

4. Endoglin and Systemic Sclerosis: A PRISMA-driven systematic review;Frontiers in Medicine;2022-08-18

5. The role of Smad signaling cascades in cardiac fibrosis;Cellular Signalling;2021-01